Related Experiment Video

Updated: Jun 6, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Clofarabine as a potential stimulant of alloreactivity

N Atimere, S Zriba, Y Hicheri

    Bone Marrow Transplantation
    |December 15, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
    09:04

    Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

    Published on: April 19, 2017

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
    11:55

    Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

    Published on: March 14, 2011

    Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
    09:04

    Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry

    Published on: April 19, 2017

    Related Concept Videos

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

    Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

    Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
    Drugs that Destabilize Microtubules01:10

    Drugs that Destabilize Microtubules

    Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...

    Articles linked to this work by shared authors, journal, and citation graph.

    Transient ischemic attack care pathways in stroke units: Findings from a French nationwide survey.

    Revue neurologique·2025

    Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.

    European journal of haematology·2023

    Tenecteplase in acute ischemic stroke: Review of the literature and expert consensus from the French Neurovascular Society.

    Revue neurologique·2022

    Safety and outcome of mechanical thrombectomy in ischaemic stroke related to carotid artery dissection.

    Journal of neurology·2021

    Impact of recanalisation by mechanical thrombectomy in mild acute ischemic stroke with large anterior vessel occlusion.

    Revue neurologique·2021

    Career aspirations among specialty residents in France: a cross-sectional gender-based comparison.

    BMC medical education·2021

    Response kinetics following CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry.

    Bone marrow transplantation·2026

    A randomized pilot trial comparing anti-thymocyte globulin with anti-thymocyte globulin plus post transplant cyclophosphamide for prophylaxis against acute and chronic graft versus host disease in matched donor hematopoietic cell transplants - a study from the Cell Therapy Transplant Canada/ Australasian Leukemia Lymphoma Group Consortium.

    Bone marrow transplantation·2026

    Long-term complications after total body irradiation in children younger than 4 years transplanted for acute lymphoblastic leukemia.

    Bone marrow transplantation·2026

    Total body irradiation across conditioning intensities: historical context, dose-fractionation strategy, and the role of the chemotherapy backbone.

    Bone marrow transplantation·2026

    Treosulfan or busulfan plus clofarabine as reduced intensity conditioning regimen before allotransplant for adults with myeloid malignancies.

    Bone marrow transplantation·2026

    Fecal microbiota transplantation in the treatment of acute graft-versus-host disease: A retrospective study performed by the Complications Working Party and Pediatric Diseases Working Party of the EBMT.

    Bone marrow transplantation·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us